Physician profile
Robert Jason Ain
NPI 1245232842
$11,657.79
in general payments reported to CMS, 2019-2025
15 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $674 · 2020: $884 · 2021: $2,158 · 2022: $4,765 · 2023: $955 · 2024: $1,159 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,177.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,000.08 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Relievant Medsystems, INC. | $1,553.42 | 2022 | |
| Medtronic USA, INC. | $1,392.67 | 2019-2020 | |
| Nalu Medical, INC. | $782.43 | 2021 | |
| Nevro Corp. | $458.85 | 2021-2022 | |
| Boston Scientific Corporation | $154.30 | 2021-2023 | Superion Indirect Decompression System |
| Collegium Pharmaceutical, INC. | $55.15 | 2019 | |
| Spinal Simplicity, LLC | $52.65 | 2021 | |
| Tersera Therapeutics LLC | $45.31 | 2019 | |
| Stryker Corporation | $34.96 | 2019 | |
| Pfizer INC. | $33.37 | 2019-2023 | |
| Amgen INC. | $33.20 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $25.79 | 2021 | |
| Idorsia Pharmaceuticals US INC | $19.33 | 2022 | |
| Eisai INC. | $16.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Ain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.